CLINICAL_TRIALS
trial_result
· 2023-03-01
Clinical Trial Update: The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study) [Phase 2]
Summary
Phase 2 clinical trial update for the LAST study evaluating outcomes after stopping tyrosine kinase inhibitors in chronic myeloid leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Medical College of Wisconsin | Conditions: Leukemia, Myeloid, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2023-03-01